Bio

Molly is a co-founder of Bourne Partners. Founded in 2001, the firm began with the targeted thesis of investing directly into healthcare companies. The advisory practice evolved soon after inception. To date, Bourne Partners has been a party to more than $10 billion of transactions in the pharmaceutical (“pharma”), pharma services, and consumer healthcare sectors. Molly advises and negotiates on technical matters with a focus on risk management and executes strategic firm initiatives. Molly is also the co-founder of Tanner Pharma Group, a pharma services company dedicated to providing managed access, commercialization, and clinical trials services to patients and partners in more than 100 countries. Molly also serves on the Board of Visitors for the Wake Forest University School of Business. Prior to Bourne Partners, she was a healthcare tax consultant with Arthur Andersen. Her practice focused on providing professional services to private physician practices and large hospital systems in the areas of merger and acquisitions, tax and joint ventures. She received a B.A. with honors in political science from The University of North Carolina at Chapel Hill and earned a J.D. and a M.B.A. from Wake Forest University. She is a licensed attorney and a member of the North Carolina State Bar and the Mecklenburg County Bar Association.